(Low dose) Aripiprazole or CBT Not More Effective Than Placebo at Preventing Transition to Psychosis

https://www.psychiatryadvisor.com/home/topics/schizophrenia-and-psychoses/aripiprazole-cbt-not-more-effective-than-placebo-preventing-transition-psychosis/

Based on overall pill count, the median aripiprazole dose was 3.8 mg/day for 164 days.

A randomized controlled trial found that neither cognitive behavioral therapy (CBT) nor low-dose aripiprazole better-prevented the transition to psychosis at 12 months compared with placebo. These findings were published in the Schizophrenia Bulletin.

10mg is the minimum dose of Abilify to act as an antipsychotic people.

1 Like